Sat, Feb
45 New Articles

New Partners and Practice at DZP


Domanski Zakrzewski Palinka has announced the promotion of two lawyers to the firm’s partnership and the creation of a new section in the firm’s IP & TMT practice.

Michal Czarnuch and Tomasz Kaczynski, both of whom have practiced within the firm’s Life Sciences Practice for several years, have become Partners at the firm. Czarnuch, who joined DZP in 2007, advises on pharmaceutical law and medical law, with special focus on the reimbursement and financing of health care services. He also advises on creating medicinal product distribution and trading systems and health protection systems, including aspects of forming and restructuring health care entities, telemedicine and health insurance. Kaczynski, who joined DZP in 2006, specializes in pharmaceutical law, including product registration, reimbursement matters, manufacturing and distribution aspects, advertising law, and clinical trial regulations. He also advises businesses in the food market on matters related to their daily operations.

In addition, the firm announced the creation of a new “R&D Section” within its IP & TMT Practice, designed to provide advice on the commercialization of scientific research and development work and technology transfer. Malgorzata Wilinska will head the new section.

Poland Knowledge Partner

Established in 1957, Wolf Theiss is one of the leading European law firms in Central, Eastern and South-Eastern Europe with a focus on international business law. With 300 lawyers in 13 offices located in Albania, Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia and Ukraine, Wolf Theiss represents local and international industrial, trade and service companies, as well as banks and insurance companies. Combining law and business, Wolf Theiss develops comprehensive and constructive solutions on the basis of legal, fiscal and business know-how.

All News about, and Legal Analysis by, Wolf Theiss can be found here.

Firm's website: http://www.wolftheiss.com/


Our Latest Issue